Impact of US-UK Trade Deal on NHS Funding
The NHS is set to redirect billions of pounds from essential services to finance new medicines as stipulated in the US-UK trade agreement finalized in December. Analysis indicates this financial shift could result in over 200,000 additional deaths.
Government and Opposition Perspectives
Government ministers have defended the trade deal, highlighting its benefits in helping British pharmaceutical exports avoid US tariffs and ensuring patient access to crucial medications. However, critics have accused the Labour party of yielding to pressure from former US President Donald Trump.
Further Discussion
Lucy Hough engages with columnist Aditya Chakrabortty for an in-depth discussion, which is available to watch on YouTube.




